LFMD LifeMD Dashboard

Conversion Labs, Inc. engages in the manufacturing, distribution, and sale of natural immune support products containing proprietary yeast beta glucans. Its products are oral intake tablets and topical creams, and gels for skin application. It operates through the Finished Cosmetic Products and Nutraceutical and Cosmetic Additives segments. The company was founded in 1987 and is headquartered in New York, NY.

Company profile

Ticker

LFMD, CVLB

Exchange

NASDAQ

Website

www.conversionlabs.com

CEO

Justin Schreiber

Incorporated

Delaware

Location

New York

Fiscal year end

Dec 31

Sector

Manufacturing > Medicinal and Botanical Manufacturing

Industry (SIC)

Services - Offices & Clinics of Doctors of Medicine

Concord Medical Services • 1life Healthcare • Teladoc Health • Medico International • Hims & Hers Health • HealthLynked • Jaws Acquisition • Envision Healthcare • China Vitup Health Care • Patient Access Solutions ...

Former names

CONVERSION LABS, INC., Immudyne, Inc.

SEC CIK

0000948320

Corporate docs

Articles of Incorporation & Bylaws

LFMD stock data

S&P 500

1M 1Y 2Y 5Y

News

Pro users get this 30m faster

66 Biggest Movers From Yesterday

31 Mar 21

Gainers

41 Stocks Moving In Tuesday's Mid-Day Session

30 Mar 21

Gainers VirTra, Inc. (NASDAQ: VTSI) shares jumped 53.6% to $7.34 after the company reported better-than-expected Q4 results.

LifeMD Q4 EPS $(2.56) Misses $(0.24) Estimate, Sales $12.90M Miss $13.64M Estimate

29 Mar 21

LifeMD (NASDAQ:LFMD) reported quarterly losses of $(2.56) per share which missed the analyst consensus estimate of $(0.24) by 966.67 percent. The company reported quarterly sales of $12.90 million which missed the

32 Stocks Moving in Monday's Pre-Market Session

29 Mar 21

Earnings Scheduled For March 29, 2021

29 Mar 21

Press releases

Pro users get this 30m faster

LifeMD Launches NavaMD™ Adding Direct-to-Patient Clinical Skincare Services to its Portfolio of Personalized Telehealth Brands

7 Apr 21

NEW YORK, April 07, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (the "Company") (NASDAQ:LFMD), a leading direct-to-patient telehealth company, today announced the successful launch of NavaMD™. The NavaMD website went

LifeMD Reports Q4 2020 Revenue up 227% to Record $12.9 Million, Full Year up 199% to Record $37.3 Million

29 Mar 21

NEW YORK, March 29, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ:LFMD), a leading direct-to-patient telehealth company, reported results for the fourth quarter and full year ended December 31, 2020. All quarterly and

LifeMD, Inc. to Host Earnings Call

29 Mar 21

NEW YORK, NY / ACCESSWIRE / March 29, 2021 / LifeMD, Inc. (NASDAQ:LFMD) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 29, 2021 at 4:30 PM Eastern Time.To listen

LifeMD to Host Fourth Quarter and Full Year 2020 Conference Call on Monday, March 29, 2021 at 4:30 p.m. ET

17 Mar 21

LifeMD Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

16 Mar 21

Investment data

Data from SEC filings

Securities sold

Number of investors

Calendar

30 Mar 21

11 Apr 21

31 Dec 21

Financial summary

Financial statements Chart LFMD financial data

Quarter (USD)	Dec 20	Sep 20	Jun 20	Mar 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 20	Dec 19	Dec 18	Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from LifeMD earnings reports.

Cash burn rate (estimated)	Burn method: Change in cash		Burn method: Operating income/loss		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	9.18M	9.18M	9.18M	9.18M	9.18M	9.18M
Cash burn (monthly)	(positive/no burn)	(positive/no burn)	11.2M	4.95M	2.18M	1.01M
Cash used (since last report)	n/a	n/a	37.79M	16.7M	7.35M	3.41M
Cash remaining	n/a	n/a	-28.61M	-7.52M	1.83M	5.77M
Runway (months of cash)	n/a	n/a	-2.6	-1.5	0.8	5.7

Beta Read what these cash burn values mean

Recent insider trades

LFMD insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
2 Apr 21	Dagnery Juan Manuel Pineiro	Common Stock, par value $0.001	Grant	Aquire A	No	No	0	10,000	0	142,182
2 Apr 21	Dagnery Juan Manuel Pineiro	Common Stock, par value $0.001	Option exercise	Aquire M	No	No	17.26	4,262	73.56K	132,182
2 Apr 21	Dagnery Juan Manuel Pineiro	Options to purchase Common Stock Common Stock, par value $0.001	Option exercise	Dispose M	No	No	17.26	4,262	73.56K	0
25 Feb 21	Brad Michael Roberts	Common Stock, par value $0.001	Buy	Aquire P	No	No	20.5	5,000	102.5K	5,000
25 Feb 21	Eric Harold Yecies	Common Stock, par value $0.001	Buy	Aquire P	No	No	20.29	1,500	30.44K	5,000
25 Feb 21	Eric Harold Yecies	Common Stock, par value $0.001	Buy	Aquire P	No	No	19.99	3,500	69.97K	3,500
24 Feb 21	Walters Happy David	Common Stock, par value $0.001	Other	Aquire J	No	No	0	800,000	0	1,336,300
24 Feb 21	Walters Happy David	Common Stock, par value $0.001	Grant	Aquire A	Yes	No	0	1,200,000	0	1,200,000
9 Feb 21	Dagnery Juan Manuel Pineiro	Common Stock, par value $0.001	Option exercise	Aquire M	No	No	26.65	59,421	1.58M	127,920
9 Feb 21	Dagnery Juan Manuel Pineiro	Common Stock, par value $0.001	Option exercise	Aquire M	No	No	26.65	13,874	369.74K	68,499

Data from 3, 4 and 5 filings. Stock values as filed, not updated for current price.

Institutional ownership Q1 2021

LFMD institutional ownership history Ownership history

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

13F holders	Current	Prev Q	Change
Total holders	0	0
Opened positions	0	0
Closed positions	0	0
Increased positions	0	0
Reduced positions	0	0

13F shares	Current	Prev Q	Change
Total value	0	0
Total shares	0	0
Total puts	0	0
Total calls	0	0
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change

Largest transactions	Shares	Bought/sold	Change

Data from 13F filings. Stock values as filed, not updated for current price. Long positions only.

Financial report summary

Competition

Icebreaker Health • GoodRx

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: abide, acclaim, accommodate, accustomed, acute, Aesthetic, allegedly, array, arriving, article, assumption, attainment, audio, AWS, bad, band, Benathen, Blue, bona, book, breakthrough, bribery, bridge, broader, Bryant, BTIG, budget, burden, burn, cadence, CAGR, calamity, campaign, capable, CCO, CCPA, cemented, certainty, Chase, cheaper, CM, commensurate, competitor, concierge, conflicting, confusion, contest, contra, contradictory, convince, COO, Corey, correspondingly, corrupt, corruption, coupled, CPRA, culture, CVLBPR, cyclical, debarment, degradation, departure, deployment, deter, deterring, Deutsch, diagnose, digestive, diligence, disbursement, disinterested, dispersed, dissatisfied, dissolved, distraction, distrust, domestic, domestically, downturn, drop, duration, ease, easily, ecommerce, Elanor, element, embedded, enrollment, entry, eventually, expedite, expedited, Expenditure, explicitly, FCPA, fide, fiduciary, finite, FINRA, flexible, flux, forfeited, forgivable, forgiven, freestanding, frustration, fullest, gather, greatly, Greenville, hand, hinder, Horizon, host, Hussey, illegal, immaterial, impede, impeded, implicit, implied, improperly, incomplete, incumbent, indemnification, indeterminate, ineligible, infeasible, injure, inorganic, input, iNRWellnessMD, insignificant, instability, intense, intensely, intensive, intercompany, JDM, landscape, laundering, lawfully, lawsuit, leader, leadership, leave, leaving, LFMD, liable, licenseed, lifemd, lifestyle, lifted, lost, lure, machinery, macroeconomic, mainstream, mandate, Marc, Mariano, match, mercy, metric, mezzanine, micro, Milestone, misconduct, mobile, modality, motivate, motivation, movement, multiplying, mutual, mutually, myriad, nascent, nationwide, Nava, NavaMD, necessitate, necessitated, noteholder, nurse, offline, onboard, onset, opposition, overwhelming, PA, pandemic, Panel, paper, partially, passage, Pathak, pause, Paycheck, permissible, phone, PIK, podcast, pool, poor, PPP, predetermined, print, processor, procure, prospective, protracted, Puopolo, quotient, radically, ratably, reaction, ready, recalculated, recapitalization, Reconciliation, recourse, redemption, referenced, reinforced, Relatedly, relaxation, remeasured, reorganization, repeal, replicate, repurposed, resell, resistance, resolution, Restoresea, Restorsea, restructure, Restructuring, revolutionizing, Ro, Roberto, robust, round, rounding, RSU, SBA, seizure, sexual, sexually, ShapiroMD, shortfall, Simon, simple, slightly, slowdown, South, staffed, staffing, steadily, steep, sterilization, STI, stigma, stoppage, streaming, strike, stronger, strongly, Subtopic, successor, superior, suspension, switch, takeover, talent, talented, taxation, Teledoc, territory, thereof, thereunder, thirteen, thirtieth, threatened, timetable, tranche, trillion, trustworthy, unaddressed, unaware, unclear, unearned, unforgiven, unfriendly, unimpeded, unintended, uninterrupted, unmarketable, unpaid, unregistered, unrest, unsettled, unwilling, usage, vandalism, Varun, verifying, vii, VWAP, week, workforce, worsen, Wyoming, younger

Removed: Academy, accountant, acknowledgment, Acorn, advice, advisor, affirmatively, aggregating, Aldridge, Allen, alternate, appeal, attempt, BA, bachelor, baker, banking, BCII, Berman, bid, biographical, blockchain, Borenstein, Bornstein, broker, Brown, Bruzzese, BS, buy, calculating, capped, caption, cellular, certified, CFO, Chairman, clear, cole, College, commercialization, commercializing, community, compensated, composition, comprising, consume, copy, Councilor, County, CPA, creative, Cruse, Dartmouth, de, dealer, decided, dependence, depth, Dermatologic, dermatologist, diagnostic, Diplomate, directed, disagreement, disciplinary, dismissed, dispositive, distribution, distributional, division, doubtful, earn, effecting, Elizabethtown, employed, encourage, ending, equally, exceeding, exemption, exercising, exhausted, existed, extension, Fellow, Florida, foamer, forfeiture, forward, founder, frame, France, Gate, glucan, graduate, great, Henderson, highest, home, Hospital, Houston, ICN, identifying, imaging, IMMD, incentivized, incremental, ineffective, innovative, internship, inventor, Island, issuing, Jersey, joined, JOJ, jury, Kalkstein, Kent, label, Landmark, language, laser, lecturer, legacy, lesser, licensing, LLP, loyalty, maximum, McLaughlin, Memorial, Miami, Michael, minimum, modification, modified, molecular, Nancy, narrative, narrower, naturally, netted, nominating, North, nutraceutical, NutraTech, OneMedPlace, optimize, Palm, participant, penny, perASC, pharmacology, Pink, planning, practicing, preceding, prevail, professor, prominent, promulgated, pronouncement, question, quotation, quoted, radiologist, Radiology, ran, ratify, recipient, reimbursed, relation, relinquish, requirement, rescinded, rescission, researcher, residency, resign, resignation, resigned, retire, retrospective, reviewing, Rhode, Rich, Richmond, Robert, Roger, Rosenberg, RRBB, salesperson, School, science, scientific, Scott, secondary, settled, shared, shown, significance, skin, Society, Sorbonne, speculation, St, standardized, standing, suit, suitability, surgery, surgical, tangible, telephone, toll, UMDNJ, unavailable, undergo, University, unvested, upheld, urology, Urovalve, vehicle, Warwick, wife, worked, worth

From filing 10-K 2020 FY